Tower Research Capital (TRC)’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,678
| Closed | -$11K | – | 6481 |
|
|
2023
Q1 | $11K | Buy |
8,678
+2,093
| +32% | +$2.65K | ﹤0.01% | 4305 |
|
|
2022
Q4 | $11K | Buy |
6,585
+937
| +17% | +$1.57K | ﹤0.01% | 3923 |
|
|
2022
Q3 | $10K | Sell |
5,648
-2,099
| -27% | -$3.72K | ﹤0.01% | 4609 |
|
|
2022
Q2 | $23K | Buy |
7,747
+6,354
| +456% | +$18.9K | ﹤0.01% | 3676 |
|
|
2022
Q1 | $10K | Buy |
1,393
+1,112
| +396% | +$7.98K | ﹤0.01% | 4394 |
|
|
2021
Q4 | $5K | Buy |
+281
| New | +$5K | ﹤0.01% | 5234 |
|
|
2021
Q3 | – | Sell |
-100
| Closed | -$1K | – | 6352 |
|
|
2021
Q2 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 5302 |
|